Healthy Skepticism Library
Items published in 2009
There are 1996 items in the Healthy Skepticism Library that were published in 2009.
Page 19 of 20 pages ‹ First < 17 18 19 20 >
HSL15061
Grassley Works to Disclose Financial Ties Between Drug Companies and Doctors
Pharma Live 2009 Jan 22
http://pharmalive.com/news/index.cfm?articleID=599737
HSL15062
GAO: High-Risk Series: An Update
Pharma Live 2009 Jan 22
http://pharmalive.com/news/index.cfm?articleID=599731
HSL14935
Fitzgerald J.
Group drops event, says doc-gift rules too strict
The Boston Herald 2009 Jan 21
http://www.bostonherald.com/business/healthcare/view.bg?articleid=1146647
HSL14936
Lafountain A.
Passing the Science Baton from R&D to Marketing
eyeforpharma.com 2009 Jan 21
http://social.eyeforpharma.com/story/passing-science-baton-rd-marketing
HSL14937
Bruderlin-Nelson C.
Are state's gift rules too strict?
Fierce Pharma 2009 Jan 21
http://www.fiercepharma.com/story/are-states-gift-rules-too-strict/2009-01-21
HSL14938
Silverman E.
Are More Rent-A-Reps On The Way?
The Invivo Blog 2009 Jan 21
http://invivoblog.blogspot.com/2009/01/are-more-rent-reps-on-way.html
HSL14939
Taylor L.
Cancer patients in England can apply for free drugs from today
PharmaTimes 2009 Jan 21
http://www.pharmatimes.com/uknews/article.aspx?id=15137&src=EWorldNews
HSL14952
Barennes H, Srour LM.
Coffee creamer as infant food: Authors’ reply to Nestlé
BMJ. 2009 Jan 21; 338:
http://www.bmj.com/cgi/content/extract/338/jan21_1/b198
HSL14953
Stieger R.
Coffee creamer as infant food: Nestlé’s works to ensure appropriate use of milk products
BMJ. 2009 Jan 21; 338:
http://www.bmj.com/cgi/content/extract/338/jan21_1/b196
HSL14956
Taylor L.
FDA “must no longer regard drug trial data as proprietary,” Obama is told
PharmaTimes 2009 Jan 21
http://www.pharmatimes.com/WorldNews/article.aspx?id=15156&src=EWorldNews
HSL15060
Edwards J.
More Zyprexa Trouble for Lilly as Insurers Want Money Too
BNET 2009 Jan 21
http://industry.bnet.com/pharma/1000620/more-zyprexa-trouble-to-come-for-lilly-as-insurers-want-money-too/
HSL17452
WU JQ
Harvard Medical School To Review Conflict of Interest Policies
The Harvard Crimson 2009 Jan 21
http://www.thecrimson.com/article/2009/1/21/harvard-medical-school-to-review-conflict/
HSL14932
Kmietowicz Z.
Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine.
BMJ. 2009 Jan 20; 338:
http://www.bmj.com/cgi/content/extract/338/jan20_1/b217
HSL14941
Staton T.
Sales force cuts have only just begun
Fierce Pharma 2009 Jan 20
http://www.fiercepharma.com/story/sales-force-cuts-have-only-just-begun/2009-01-20
HSL17035
Bland B
Indonesian doctors are told to prescribe generics to reduce health costs
BMJ 2009 Jan 20;
http://www.bmj.com/cgi/content/extract/340/jan20_2/c349
HSL14912
HAI.
New international rules on patents make medicines more expensive
HAI 2009 Jan 19
HSL14933
Hill M.
Whistle-blower’s perspective on Lilly case
The Philadelphia Inquirer 2009 Jan 19
http://www.philly.com/inquirer/breaking/business_breaking/20090119_Whistle-blowers_perspective_on_Lilly_case.html
HSL14940
Pfizer UK hints at disclosure of payments to doctors
Pharmafocus 2009 Jan 19
http://www.pharmafocus.com/cda/focusH/1,2109,21-0-0-JAN_2009-focus_news_detail-0-492423,00.html
HSL14942
Tanne JH.
FDA allows drug firms to distribute journal articles about unapproved uses.
BMJ. 2009 Jan 19; 338:b187:
http://www.bmj.com/cgi/content/extract/338/jan19_2/b187?papetoc
HSL14948
Medew J.
Doctors call for review of cancer treatments
The Sydney Morning Herald 2009 Jan 19
http://www.smh.com.au/news/national/doctors-call-for-review-of-cancer-treatments/2009/01/18/1232213448313.html
HSL14955
Fate of Generics Hinges on Bayer Case
Times of India 2009 Jan 19
http://www.cbgnetwork.org/2793.html
HSL14957
Reed J.
Tell us about drug co links, say patients
6minutes.com 2009 Jan 19
http://web.archive.org/web/20101120030844/http://6minutes.com.au/articles/z1/view.asp?id=435212
HSL15086
Mukherjee R.
Fate of generics hinges on Bayer case
The Times of India 2009 Jan 19
http://timesofindia.indiatimes.com/Fate_of_generics_hinges_on_Bayer_case/rssarticleshow/3998349.cms
HSL17057
Iskowitz M
Pfizer nearly doubles amount spent on e-detailing
Medical Marketing & Media 2009 01 19
http://www.mmm-online.com/pfizer-nearly-doubles-amount-spent-on-e-detailing/article/161727/
HSL17078
Pierson R, Berkro B
Pfizer eyes bigger push into emerging markets
Reuters 2009 Jan 19
http://www.reuters.com/article/idUSN1922426720100119
HSL15087
Singh K, Dey S.
No antidote to stop copies of patented drugs: Health min
The Economic Times 2009 Jan 17
http://economictimes.indiatimes.com/News/News_By_Industry/Healthcare__Biotech/Pharmaceuticals/No_antidote_to_stop_copies_of_patented_drugs_Health_min/articleshow/3991463.cms
HSL18482
Akaleephan C, Wibulpolprasert S, Sakulbumrungsil R, Luangruangrong P, Jitraknathee A, Aeksaengsri A, Udomaksorn S, Tangcharoensathien V, Tantivess S.
Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: Analysis of the effect of TRIPs-Plus proposal
Health Policy 2009 Jan 17; 91:(2):174-82
http://www.journals.elsevierhealth.com/periodicals/heap/article/S0168-8510(08)00286-8/abstract
HSL14927
Anderson M.
No More Drug Company Pens: A Trojan Horse?
The Social Medicine Portal 2009 Jan 16
http://www.socialmedicine.org/2009/01/16/big-pharma/no-more-drug-company-pens-a-trojan-horse/
HSL14949
Rubenstein S.
Medtronic Pays Surgeon ‘$20,000 or More’ — Much, Much More
The Wall Street Journal 2009 Jan 16
http://blogs.wsj.com/health/2009/01/16/medtronic-pays-surgeon-20000-or-more-much-much-more/
HSL17472
Armstrong D, Burton TM
Medtronic Paid Researcher More Than $20,000 -- Much More
The Wall Street Journal 2009 Jan 16
http://online.wsj.com/article/SB123206035479087601.html?mod=googlenews_wsj
HSL17473
Fauber J
Medical device maker paid UW surgeon $19 million
The Journal Sentinel 2009 Jan 16
http://www.jsonline.com/news/wisconsin/37748554.html
HSL17475
Andrews A
Scrutiny of Doctor-Pharma Ties Leads to Change
ProPublica 2009 Jan 16
http://www.propublica.org/article/scrutiny-of-doctor-pharma-ties-leads-to-change-090116
HSL14868
Angell M.
Drug Companies & Doctors: A Story of Corruption
The New York Review of Books 2009 Jan 15
http://www.nybooks.com/articles/22237
HSL14904
Harris G.
Lilly Said to Be Near $1.4 Billion U.S. Settlement
The New York Times 2009 Jan 15
http://www.nytimes.com/2009/01/15/business/15drug.html
HSL14921
Cronin Fisk M, O’Reilly C.
Lilly to Pay Biggest Fine Ever to End Zyprexa Probe
Bloomberg.com 2009 Jan 15
http://www.bloomberg.com/apps/news?pid=20601087&sid=aGDAxYMRGIw0
HSL14922
Richwine L.
U.S. lets drugmakers advise doctors on unapproved uses
Reuters 2009 Jan 15
http://www.reuters.com/article/email/idUSTRE50B5GK20090112
HSL14945
US Department of Justice
Pharmaceutical Company Eli Lilly To Pay Record
US Department of Justice 2009 Jan 15
http://www.usdoj.gov/usao/pae/News/Pr/2009/jan/lillyrelease.pdf
HSL14951
Frankston Lorin J, Lauerman J.
Harvard Medical School to Review Drug Research Ethics
Bloomberg.com 2009 Jan 15
http://www.bloomberg.com/apps/news?pid=20601103&sid=aD6RpDNyYKko&refer=us
HSL14931
Mundy A, Favole J.
Glaxo's Emails on Avandia Reveal Concern
The Wall Street Journal 2009 Jan 14
http://online.wsj.com/article/SB123190610976680477.html?mod=googlenews_wsj
HSL14934
O'Riordan M.
Reps Can Distribute Info About Off-Label Drug and Device Use, Says the FDA
Medscape Today 2009 Jan 14
http://www.medscape.com/viewarticle/586801?src=mp&spon=17&uac=36327PX
HSL15089
Goldacre B.
Pay to play?
Bad Science 2009 Jan 14
http://www.badscience.net/2009/02/pay-to-play/
HSL14902
Fleg A.
Unbranding the doctor’s office
The New Mexico Independent 2009 Jan 13
http://newmexicoindependent.com/14749/unbranding-the-doctors-office
HSL14925
Not What We Call Due Diligence
The New York Times 2009 Jan 13
http://www.nytimes.com/2009/01/13/opinion/13tue2.html?_r=1
HSL14926
Staton T.
Suddenly, everyone's a DTC critic
Fierce Pharma 2009 Jan 13
http://www.fiercepharma.com/story/suddenly-everyones-dtc-critic/2009-01-13
HSL14947
Meier B.
Device Maker Sues a Doctor Who Called Its Product Flawed
The New York Times 2009 Jan 13
http://www.nytimes.com/2009/01/14/health/research/14heartside.html?_r=2&ref=research
HSL14950
Singer N.
Love the Long Eyelashes. Who’s Your Doctor?
The New York Times 2009 Jan 13
http://www.nytimes.com/2009/01/14/health/research/14lash.html?_r=1&emc=eta1
HSL14943
Finucane TE.
Men, androgen deficiency, and pharmaceutical promotion.
Arch Intern Med. 2009 Jan 12; 169:(1):88
http://archinte.ama-assn.org/cgi/content/full/169/1/88
HSL14959
Fauber J.
Drug firms wine, dine and pay up for doctors' speeches
Journal Sentinel 2009 Jan 12
http://www.jsonline.com/features/health/37421114.html
HSL14966
Alonso-Zaldivar R.
Report: FDA screening of researchers is unreliable
The Associated Press 2009 Jan 12
http://www.statesman.com/search/content/news/stories/nation/01/12/0112fdaconflicts.html
HSL14923
Campbell D.
NHS patients to get better drug access
Guardian.co.uk 2009 Jan 11
http://www.guardian.co.uk/society/2009/jan/11/health-nhs-pharmaceuticals-drugs
HSL14958
Fauber J.
Doctors face pressure to disclose all side pay
Journal Sentinel 2009 Jan 11
http://www.jsonline.com/features/health/37397284.html
HSL14887
Ramshaw E.
Bills seek disclosure of pharmaceutical companies' payments to doctors
Dallas News.com 2009 Jan 10
http://web.archive.org/web/20100116001309/http://www.dallasnews.com/sharedcontent/dws/dn/latestnews/stories/011009dntexpharma.3e0964b.html
HSL14908
Rice M.
Paying the piper
The Sydney Morning Herald 2009 Jan 10
http://www.smh.com.au/news/national/paying-the-piper/2009/01/09/1231004286970.html
HSL14903
Mundy A.
Regulator's Clothing: Drug Industry Critic Joins the FDA
The Wall Street Journal 2009 Jan 9
http://online.wsj.com/article/SB123145489435265929.html?mod=googlenews_wsj
HSL14920
Harris G.
Medical Journal Changes Its Policy After Criticism by Group
The New York Times 2009 Jan 9
http://www.nytimes.com/2009/01/09/us/09journal.html?_r=1
HSL14954
Apotex Inc.: A Corporation Above the Courts?
Canadian Association of University Teachers 2009 Jan 9
http://www.caut.ca/pages.asp?page=734
HSL14886
Landefeld CS, Steinman MA.
The Neurontin Legacy: Marketing Misinformation and Manipulation
The New England Journal of Medicine 2009 Jan 8; 360:(2):103
http://content.nejm.org/cgi/content/full/360/2/103
HSL14889
Lentini NM.
Wyeth Ads Encourage: 'Say Yes To Advil'
Marketing Daily 2009 Jan 8
http://www.mediapost.com/publications/?fa=Articles.san&s=97981&Nid=51055&p=448587
HSL14890
Thomaselli R.
'Morning-After Pill' Catches Flak for MTV.com Ad
The Advertising Adage 2009 Jan 8
http://adage.com/article?article_id=133632
HSL14891
Connolly C.
With More Oversight on the Horizon, Drugmakers Work to Polish Image
The Washington Post 2009 Jan 8
http://www.washingtonpost.com/wp-dyn/content/article/2009/01/07/AR2009010703869.html
HSL14913
Herper M.
The Value Of New Drugs Is Dropping
Forbes.com 2009 Jan 8
http://www.forbes.com/2009/01/07/pharmaceuticals-sales-biz-healthcare-cx_mh_0108drugssales.html
HSL14914
Rubenstein S.
Drug Industry Hustles to Blunt Democratic Strikes
The Wall Street Journal Blog 2009 Jan 8
http://blogs.wsj.com/health/2009/01/08/drug-industry-hustles-to-blunt-democratic-strikes/
HSL14924
Sweney M.
Sex drug poster ads to be taken down
Guardian.co.uk 2009 Jan 8
http://www.guardian.co.uk/media/2009/jan/08/sex-drug-ads-taken-down
HSL14960
Monash D.
Time to put pharmacists under the microscope
Crikey 2009 Jan 8
http://www.crikey.com.au/Politics/20090108-Why-its-time-to-put-pharmacy-under-scrutiny.html
HSL14900
Hirji KF.
No short-cut in assessing trial quality: a case study.
Trials 2009 Jan 7; 10:(1):
www.trialsjournal.com/content/10/1/1
HSL14901
Gøtzsche PC.
Readers as research detectives
Trials 2009 Jan 7; 10:(1):
www.trialsjournal.com/content/10/1/2
HSL14915
Hopkins Tanne J.
US university psychiatrist loses chairmanship over drug company payments..
BMJ. 2009 Jan 6; 338:a3188:
http://www.bmj.com/cgi/content/extract/338/jan05_3/a3188
HSL14880
Taylor L.
German govt 'to force drugmakers to sell through wholesalers'
Pharma Times 2009 Jan 5
http://www.pharmatimes.com/WorldNews/article.aspx?id=15023&src=EWorldNews
HSL14881
Stepping into the therapeutics void.
Coombes R.
BMJ. 2009 Jan 5; 338:a3179:
http://www.bmj.com/cgi/content/full/338/jan05_2/a3179
HSL14882
Pharmaceutical Research and Manufacturers of America Enacts New Voluntary Guidelines on Physician Gifting Practices
Kaiser Daily Health Policy Report. 2009 Jan 5
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=56245
HSL14885
Change in FDA's ethical guidelines for clinical trials troubling: Lancet
CBC News 2009 Jan 5
http://www.cbc.ca/health/story/2009/01/05/fda.html
HSL14910
Coombes R.
Stepping into the therapeutics void.
BMJ. 2009 Jan 5; 338:a3179:
http://www.bmj.com/cgi/content/extract/338/jan05_2/a3179
HSL14916
New Year Resolution: Stand Up to Healthcare Marketing Hypocrisy!
Trusted.MD 2009 Jan 5
http://trusted.md/blog/hippocrates/2009/01/06/new_year_resolution_stand_up_to_healthcare_marketing_hypocrisy
HSL14918
Staton T.
Shrinking sales forces face constraints
Fierce Pharma 2009 Jan 5
http://www.fiercepharma.com/story/shrinking-sales-forces-face-constraints/2009-01-03
HSL14919
Staton T.
Congress mandates disclosure
Fierce Pharma 2009 Jan 5
http://www.fiercepharma.com/story/show-us-yours-well-show-you-ours/2009-01-03
HSL14883
No Mugs, but What About Those Fees
The New York Times 2009 Jan 4
http://www.nytimes.com/2009/01/05/opinion/05mon1.html
HSL17010
Silverman E
Drugging Kids for Profit
Portfolio.com 2009 Jan 4
http://www.portfolio.com/industry-news/health-care/2010/01/04/drugging-kids-for-profit/index1.html
HSL14909
Tyrer P, Kendall T.
The spurious advance of antipsychotic drug therapy
The Lancet 2009 Jan 3; 373:(9657):4-5
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61765-1/fulltext
HSL14911
Kimmelman J, Weijer C, Meslin EM.
Helsinki discords: FDA, ethics, and international drug trials
The Lancet 2009 Jan 3; 373:(9657):13-4
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61936-4/fulltext
HSL14869
Pringle E.
SSRI Pushers under Fire
Scoop 2009 Jan 2
http://www.scoop.co.nz/stories/HL0901/S00008.htm
HSL14917
AMSA Applauds Pharma Ban; Continues to Call for Federal Regulation
Pharma Live 2009 Jan 2
http://pharmalive.com/news/index.cfm?articleID=595275
HSL18635
Dantzer S
Perspective: Communicating Medical News—Pitfalls of Health Care Journalism
New England Journal of Medicine 2009 Jan 1; 360:1- 3
http://www.nejm.org/doi/full/10.1056/NEJMp0805753
HSL14841
Poole D, Bertolini G, Garattini S.
Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis.
Lancet Infect Dis 2009 Jan; 9:(1):67-72
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(08)70306-2
HSL14893
Kyle GJ, Nissen LM, Tett SE
The Australian rise of esomeprazole-was expenditure on samples a contributor?
Pharmacoepidemiol Drug Saf. 2009 Jan; 18:(1):62-8
http://www3.interscience.wiley.com/journal/121587742/abstract?CRETRY=1&SRETRY=0
HSL14907
Clauson KA, Khanfar NM, Polen HH, Gibson F.
Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives.
J Clin Nurs 2009 Jan; 18:(2):228-33
http://www3.interscience.wiley.com/journal/121562111/abstract
HSL15001
Levinson DR
The Food and Drug Administration’s Oversight of Clinical Investigator’s Financial Information
: FDA 2009 Jan
http://www.oig.hhs.gov/oei/reports/oei-05-07-00730.pdf
HSL15017
Thawani V, Gharpure K.
Monitoring misuse of the WHO name and emblem in medicine promotion in India
Indian Journal of Medical Ethics 2009 Jan-Mar; 17:(1):epub
http://www.ijme.in/171ar10
HSL15048
Klemperer D.
[Self-help groups conflicts of interest through sponsoring by the pharmaceutical industry].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009 Jan; 52:(1):71-6
http://www.springerlink.com/content/92x3337327075725/
HSL15054
Shankar PR, Piryani RM
Medical education and medical educators in South Asia - a set of challenges.
J Coll Physicians Surg Pak. 2009 Jan; 19:(1):52-6
http://www.ncbi.nlm.nih.gov/pubmed/19149982
HSL15234
Spake DF, Joseph M, Finney RZ.
Urban senior citizens' versus rural consumers' views of DTC advertising: A preliminary investigation
Journal of Medical Marketing 2009 Jan; 9:(1):21–28
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200817a.html
HSL15235
Kelly D, Rupert E.
Professional emotions and persuasion: Tapping non-rational drivers in health-care market research
Journal of Medical Marketing 2009 Jan; 9:(1):3–9
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200828a.html
HSL15322
Joseph JN, Deaton D, Ehsan H, Bonanno MA
Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
J Health Life Sci Law 2009 Jan; 2:(2):73-108
http://www.ncbi.nlm.nih.gov/pubmed/19288889
HSL15439
Hall J, Noyce P, Cantrill JHow do district nurses choose which products to prescribe.
How do district nurses choose which products to prescribe?
Br J Community Nurs. 2009 Jan; 14:(1):12,
http://www.ncbi.nlm.nih.gov/pubmed/19363864
HSL17087
Heinemann L.
Trust: Need for an Improved Communication between the Public World and the Pharmaceutical Companies.
J Diabetes Sci Technol 2009 Jan; 3:(1):210-2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769856/?tool=pubmed
HSL19336
Stossel TP.
AACE and ACRE: Harmony of Interests.
Endocr Pract 2009; 15:(7):671
http://aace.metapress.com/content/9672618x727134v6/
HSL19027
Barry DA, Baines CJ, Baum M, Dickersin K, Fletcher SW, Gøtzsche PC, Jørgensen KJ, Junod B, Maehlen J, Schwartz LM, Welch HG, Woloshin S, Thornton H, Zahl PH.
Flawed inferences about screening mammography's benefit based on observational data.
J Clin Oncol 2009 1; 27:(4):639-40
http://jco.ascopubs.org/content/27/4/639.long
HSL19330
Rose L, Garrow J.
False claims in health care: outlawed at last?
Med Leg J 2009; 77:(Pt 2):66-8.
http://mlj.rsmjournals.com/
HSL19023
Woloshin S, Schwartz LM, Kramer BS.
Promoting healthy skepticism in the news: helping journalists get it right.
Natl Cancer Inst 2009 2; 101:(23):1596-9
http://jnci.oxfordjournals.org/content/101/23/1596.long
HSL14552
Global pharma market forecast to exceed $820bn in 2009
Manufacturing Chemist 2009
http://www.ims-japan.co.jp/pr_20081029.php
HSL14929
Tattersall MHN, Dimoska A, Gan K.
Patients expect transparency in doctors’ relationships with the pharmaceutical industry
eMJA 2009; 2:65-68
http://www.mja.com.au/public/issues/190_02_190109/tat10368_fm.html
Page 19 of 20 pages ‹ First < 17 18 19 20 >
